Official Title
Evaluation of Psychological Impact of Group Therapy for Patients Who Have Been Hospitalized in Intensive Care During COVID-19 Pandemic: Exploratory Study
Brief Summary

Psychological impact of intensive care hospitalization for patients has been demonstrated during the last few years: anxiety, depression and post traumatic stress disorder. Hospitalizations during COVID-19 pandemic have been marked by factors such as confinement forbidding family members visits, stress on intensive care unit ...Those factors may have a psychological impact added to factors of long hospitalization and prolonged mechanical ventilation. For all these reasons the investigators fear that patients hospitalized in intensive care during COVID-19 pandemic develop psychological trouble with an increased risk for those who experienced COVID-19 infection. The hypothesis therapy group added to standard care might have a positive impact on psychological troubles such as anxiety, depression and post traumatic stress disorder for patients who have been hospitalized in intensive care during COVID-19 pandemic. The investigators will compare two groups: - group receiving standard of care - group receiving standard of care and therapy group

Active, not recruiting
Intensive Care Unit Syndrome
COVID19
Anxiety
Depression

Other: therapy group

therapy group of maximum 8 people repeated twice

Eligibility Criteria

Inclusion Criteria:

- 18 years old and older

- hospitalized at least 72h in intensive care during COVID-19 pandemic crisis

- out of intensive care for at least 2 months and maximum 6 months

- psychological evaluation done according to local practice and standard of care

- speaking french

- patient coming alone to the therapy group

- patient agree to respect confidentiality rules and demonstrating goodwill with others
participants

- patient comite to respecting barriers rules against COVID-19

- affiliated to social security system

- no juridic protection engaged

Exclusion Criteria:

- presenting psychological disease

- drug addiction

- participation to other interventional clinical trial

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
France
Locations

CH Métropole Savoie
Chambéry, France

Romain PERCOT, Study Director
Cebtre Hospitalier Metropole Savoie

Centre Hospitalier Metropole Savoie
NCT Number
MeSH Terms
COVID-19